Recurring nodular scleritis following inactivated vaccination for COVID-19.
Alireza PeymanMohsen PouraziziShakiba DehghaniSarah GhorbaniPublished in: Clinical case reports (2023)
Since the COVID-19 global outbreak, many types of vaccines have been introduced. These vaccines have been associated with some adverse effects including ocular manifestations. Herein, we report a case of a patient who developed nodular scleritis shortly after receiving the first and second doses of the inactivated COVID-19 vaccine, Sinopharm.
Keyphrases